The ECTRIMS 2024 Patient Community Day participants will dive into an exciting and informative programme featuring two interactive sessions. They will explore the forefront of multiple sclerosis research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. Additionally, they will discover promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies.
15:00 – 15:10 CEST
Introduction
15:10 – 16:10 CEST
Session 1 will explore the latest advancements in remyelination and myelin repair, delve into emerging therapies targeting progressive MS, and examine the role of risk factors such as EBV. It will also discuss the impact of lifestyle modifications on MS, including diet, exercise, and environmental factors, alongside strategies for managing symptoms and enhancing cognition. Additionally, the session will address diversity in clinical trials and registries.
Chair
Bruno Stankoff
Moderator
Brett Drummond
Panelists
Timothy Coetzee; Malene Kappen Krüger; Melinda Magyari; Mar Tintoré; Mitzi Joi Williams
16:10 – 16:20 CEST
Break
16:20 – 17:20 CEST
Session 2 will focus on an array of topics including the McDonald Criteria for diagnosing multiple sclerosis, challenges and strategies in paediatric MS, advances in MS nursing practices, and the latest updates on Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD).
Chair
Bruno Stankoff
Moderator
Brett Drummond
Panelists
Sumaira Ahmed; Kumaran Deiva; K-J Lazarus; Ciara O’Meara; Romain Marignier; Finn Sellebjerg
17:20 – 17:30 CEST
Closing
17:30 – 18:00 CEST
Networking
